Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Danaher Corporation (DHR) vs Kraft Heinz Co (KHC) Price & Performance

Danaher CorporationTrade
Kraft Heinz CoTrade

Price performance (Past 24H)

Key statistics

Danaher Corporation vs Kraft Heinz Co — how do they compare? Danaher Corporation trades at $218.2 (market cap $152.87B), while Kraft Heinz Co trades at $22.37 (market cap $26.66B). The key difference: Danaher Corporation is far larger — about 5.7× Kraft Heinz Co's market cap, and Kraft Heinz Co pays the higher dividend (7.12%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Kraft Heinz Co for 129 Days on average.

DHRKHC
Market Cap
$152.87B$26.66B
Volume
5,228,69831,300,109
Sector
HealthConsumer Staples
52-Week High
$242.05$27.62
52-Week Low
$161.91$21.21
Typical Hold Time
69 Days129 Days
Enterprise Value
$175.08B$42.98B
Dividend Yield
0.74%7.12%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Danaher Corporation

Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.

The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.

Kraft Heinz Co

Kraft Heinz (KHC) trades at $21.98, down 0.23% on the day, with a bearish technical signal and mixed fundamentals. The company reported a net loss of $5.85 billion in 2025 due to a significant impairment charge, though it has beaten EPS estimates for three consecutive quarters. Positive operating cash flow of $4.46 billion and a dividend yield near 7.3% provide some support, but high debt and declining revenue pose challenges.

The outlook remains cautious with a consensus price target of $23.78 suggesting modest upside. Risks include persistent volume declines, high leverage, and competitive pressures. The stock's deep value metrics (P/E of 13.04, P/B of 0.74) may attract contrarian investors, but sustained profitability improvement is needed for a durable rebound.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DHR
18% Buy82% Sell
Avg holding period · 69 Days
KHC
100% Buy0% Sell
Avg holding period · 129 Days

Top news

Latest headlines on both assets

About Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

Read more on DHR →

About Kraft Heinz Co

In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.

Read more on KHC →